Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

ALL # A B C D E F G H I K L M N O P Q R S T U V W Z

Clear all filters

Displaying 26 projects and 1 programmes

Accelerate.EU

Elevating the future of cancer care with alpha theranostics

GUIDE.MRD

Guiding multi-modal therapies against MRD by liquid biopsies

Ongoing IHI Cancer

IDERHA

Integration of heterogeneous data and evidence towards regulatory and HTA acceptance

Ongoing IHI Cancer Digital health Big data and knowledge management Real-world data, evidence Imaging Artificial intelligence

ILLUMINATE

Increasing lutetium production, while leveraging metabolic imaging to enhance theranostics effectiveness

Ongoing IHI Cancer Diagnostics Manufacturing technologies Imaging

IMAGIO

Imaging and advanced guidance for workflow optimization in interventional oncology

Ongoing IHI Cancer Drug delivery Imaging

Synthetic healthcare data governance hub

Ongoing IHI Cardiovascular diseases Cancer Big data and knowledge management Artificial intelligence

SYNTHIA

Synthetic data generation framework for integrated validation of use cases and AI healthcare applications

Ongoing IHI Diabetes & metabolic disorders Neurodegenerative diseases Cancer Alzheimer's disease Big data and knowledge management Real-world data, evidence

Thera4Care

Theranostics ecosystem for personalised care

Ongoing IHI Cancer Clinical trial design Manufacturing technologies Imaging

BD4BO

Big Data for Better Outcomes

Ongoing IMI2 Cardiovascular diseases Neurodegenerative diseases Cancer Alzheimer's disease BD4BO Patient involvement in R&D Big data and knowledge management Real-world data, evidence

H2O

H2O Health outcomes observatory

Ongoing IMI2 Diabetes & metabolic disorders Autoimmune diseases Cancer Patient involvement in R&D Real-world data, evidence

HARMONY

Healthcare alliance for resourceful medicines offensive against neoplasms in hematology

Closed IMI2 Cancer BD4BO Big data and knowledge management Real-world data, evidence

HARMONY PLUS

Healthcare alliance for resourceful medicines offensive against neoplasms in hematology – PLUS

Ongoing IMI2 Cancer BD4BO Big data and knowledge management Real-world data, evidence

IMMUCAN

Integrated immunoprofiling of large adaptive cancer patients cohorts

Ongoing IMI2 Cancer Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety

imSAVAR

Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Ongoing IMI2 Autoimmune diseases Cancer 3Rs - animal use in research

ITCC-P4

ITCC pediatric preclinical POC platform

Ongoing IMI2 Cancer Tools for predicting/monitoring safety Tools for pediatrics

OPTIMA

Optimal treatment for patients with solid tumours in Europe through artificial intelligence

Ongoing IMI2 Cancer Real-world data, evidence Artificial intelligence

PERSIST-SEQ

Building a reproducible single-cell experimental workflow to capture tumour drug persistence

Ongoing IMI2 Cancer Disease taxonomy

PIONEER

Prostate cancer diagnosis and treatment enhancement through the power of big data in Europe

Closed IMI2 Cancer BD4BO Big data and knowledge management

PROTECT-trial

Proton versus photon therapy for esophageal cancer - a trimodality strategy

Ongoing IMI2 Cancer Conducting clinical trials

SISAQOL-IMI

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Ongoing IMI2 Cancer Clinical trial design Patient involvement in R&D Regulatory and HTA processes

T2EVOLVE

Accelerating development and improving access to CAR and TCR-engineered T cell therapy

Ongoing IMI2 Cancer Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Manufacturing technologies

CANCER-ID

Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood

Closed IMI1 Cancer Tools for predicting/monitoring efficacy

EBiSC

European Bank for induced pluripotent Stem Cells

Closed IMI1 Cardiovascular diseases Diabetes & metabolic disorders Neurodegenerative diseases Cancer Alzheimer's disease Biobanks Stem cells

MARCAR

Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis

Closed IMI1 Cancer Tools for predicting/monitoring efficacy 3Rs - animal use in research Imaging

Onco Track

Methods for systematic next generation oncology biomarker development

Closed IMI1 Cancer Tools for predicting/monitoring safety

Predect

New models for preclinical evaluation of drug efficacy in common solid tumours

Closed IMI1 Cancer

Quic-Concept

Quantative imaging in cancer:connecting cellular process with therapy

Closed IMI1 Cancer Disease taxonomy Imaging